HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin sensitivity and glycemic control before and after parathyroidectomy in a diabetic patient with familial multiple endocrine neoplasia type 1.

Abstract
We treated a diabetic patient with familial multiple endocrine neoplasia type 1 (MEN 1) who had undergone total pancreatoduodenectomy. The patient received insulin and showed signs of symptomatic primary hyperparathyroidism (PHPT). The insulin requirement to control blood glucose before and after parathyroidectomy was compared by using an artificial pancreas. The insulin infusion rate during the day and at night was reduced to about one-third and half, respectively, after parathyroidectomy with autotransplantation of parathyroid tissues into the forearm. The daily insulin dose was reduced from 36 units to 14 units 2 weeks after surgery, and glycemic control showed further improvement 2 months after surgery with the same dose of insulin for up to 6 months. These observations suggest that insulin sensitivity increases after surgical correction of PHPT.
AuthorsS Furuto-Kato, A Shimatsu, H Kuzuya, K Matsuda, K Nakao, H Imura
JournalEndocrine journal (Endocr J) Vol. 41 Issue 6 Pg. 731-5 (Dec 1994) ISSN: 0918-8959 [Print] Japan
PMID7704099 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Blood Glucose
  • Insulin
Topics
  • Adult
  • Blood Glucose (metabolism)
  • Diabetes Complications
  • Diabetes Mellitus (blood, drug therapy)
  • Female
  • Humans
  • Insulin (administration & dosage, pharmacology, therapeutic use)
  • Insulin Infusion Systems
  • Multiple Endocrine Neoplasia Type 1 (blood, complications, surgery)
  • Pancreaticoduodenectomy
  • Parathyroidectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: